Alpen Pharma

What Alpen Pharma does

Alpen Pharma AG is a privately held Swiss pharmaceutical company headquartered at Finkenhubelweg 16, 3012 Bern, Switzerland. Founded circa 2000, the company operates as a producer, promoter, and distributor of pharmaceutical and para-pharmaceutical products, with representative offices and country-level websites in 26+ markets across Europe, the Caucasus, Central Asia, and Southeast Asia. Its core offering combines pharmaceutical distribution with partnership-based market-entry support, including scientific and clinical trial collaboration and product-development services for partner principals seeking access to emerging markets. A stated sub-brand, Dr. Gustav Klein GmbH, represents the group at industry events such as Expopharm Dusseldorf. The company holds a Swiss Good Distribution Practice (GDP) certification (GDP-CH-1005443, renewed from a February 2021 predecessor) as its primary regulatory credential.

The business model is B2B and partnership-driven: Alpen Pharma does not sell to end consumers but instead functions as a regional distribution and market-access platform for pharmaceutical manufacturers and research organizations. Go-to-market is executed through enterprise field sales via in-country representative offices, supplemented by participation in major pharmaceutical trade fairs and an annual International Workshop program that gathers staff and partners across markets (the 2018 Baku workshop hosted nearly 370 participants from 20+ countries). Pricing and contract terms are not publicly disclosed; commercial relationships are structured individually per partner, consistent with a project- and distribution-based revenue model rather than a standardized subscription or SaaS-style arrangement. Headcount is reported in the 501–1,000 range. Ownership is founder/management-controlled, with no disclosed parent company, external investors, funding rounds, subsidiaries, M&A, or leadership changes in the available data.

The company maintains 26 dedicated country websites (covering markets such as Ukraine, Germany, Switzerland, Kazakhstan, Uzbekistan, Vietnam, Mongolia, and the Baltics and Balkans), a press center for media distribution, and a digital marketing stack built on Google Analytics, AdSense, AdWords conversion tracking, and DoubleClick remarketing. There is no disclosed proprietary technology platform, AI/ML capability, patents, or trademarks; competitive differentiation rests on geographic reach, regulatory compliance (Swiss GDP), and the depth of in-country partner relationships rather than on technology assets.

Name

Alpen Pharma

Legal name

Alpen Pharma AG

Website

https://alpenpharma.ch

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Alpen Pharma AG is a privately held Swiss pharmaceutical distributor and partnership platform, headquartered in Bern, with representative offices in 26+ countries across Europe, Central Asia, and Southeast Asia, serving pharmaceutical principals seeking emerging-market entry and distribution.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing and Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industries

Specialty Pharmaceutical Distributors (HLAIAJAB), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

Keywords

• Pharmaceutical manufacturing
• Pharmaceutical distribution
• Para-pharmaceutical products
• Market expansion services
• Clinical trial support

Headquarters

HQ city

Bern

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical and Para-Pharmaceutical Products: Alpen Pharma operates in pharmaceutical and para-pharmaceutical fields, offering a broad range of services to support partners' ideas and products at all stages of business, including market entry and expansion support.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Core offering

Alpen Pharma AG is a Swiss-headquartered pharmaceutical company that produces, promotes, and distributes medical and para-pharmaceutical products. Through a network of representative offices in 26+ countries, the company provides partnership-based market entry, distribution, scientific and clinical trial support, and expansion services to pharmaceutical manufacturers and organizations targeting emerging markets in Europe, Central Asia, the Caucasus, and Southeast Asia.

Product overview

Alpen Pharma is an international pharmaceutical company with Alpen Pharma AG as its core entity headquartered in Bern, Switzerland. The company operates through its sub-brand Dr. Gustav Klein pharmaceutical company and maintains representative offices across more than 25 countries in Europe, Central Asia, and Southeast Asia. The product portfolio encompasses pharmaceutical and para-pharmaceutical products, supported by services including global market development, scientific and clinical trials, and partnership programs with regional teams providing expert support for product introduction in emerging markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Alpen Pharma AG Pharmaceutical Products Pharmaceutical and para-pharmaceutical products manufactured and distributed globally through representative offices in 26+ countries. Targeted at pharmaceutical industry partners, research centers, and organizations seeking market entry and expansion support.
• Dr. Gustav Klein Pharmaceutical Brand
• Alpen Pharma Partnership Program

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Open Partnership ModelcoreOthersAlpen Pharma operates as an international company open to partnerships with other companies, organizations, and research centers. Their flexible structure creates conditions for long-term and fruitful cooperation with an individual approach to each partner. The company leverages capabilities, experience, and resources from partners to better meet patients' needs.

Scale indicators5 records

Recent moves5 records

Expansion highlights3 records

Others

• Helm AG: Hamburg-based distribution and marketing company for life-science and pharmaceutical principals. Comparable as a long-cycle, partnership-led pharma distributor serving emerging markets, though without owned manufacturing.

Direct peers

• KRKA: Slovenian pharma manufacturer and distributor with strong CEE and CIS presence and broad generic portfolio. Comparable on the manufacturer-plus-distributor hybrid model serving emerging European markets.
• Polpharma: Polish pharma manufacturer with one of the largest generic and OTC portfolios in CEE. Comparable as a Central European manufacturer-distributor with multi-country commercial reach in overlapping geographies.
• Gedeon Richter: Hungarian branded-generic pharma with pan-CEE and CIS commercial reach. Comparable as a CEE-rooted manufacturer using in-country distribution to commercialize across the same emerging markets Alpen serves.
• Hikma Pharmaceuticals: Jordan-headquartered specialty pharma with manufacturing and distribution across MENA, Europe, and North America. Comparable in the 'Western-quality manufacturer with emerging-market-led commercial footprint' positioning.
• Sopharma: Bulgarian pharma manufacturer-distributor with broad portfolio and presence in CEE and CIS. Comparable as a regional manufacturer-distributor in overlapping emerging European markets.
• Stada Arzneimittel: Private German specialty pharma group with generics and consumer health, deep distribution across Central and Eastern Europe, CIS, and other emerging markets. Most directly comparable to Alpen Pharma on the combination of branded/generic manufacturing plus emerging-market distribution at country level.
• Zentiva: Pan-European generics manufacturer and distributor headquartered in Prague with strong CEE footprint. Comparable on the CEE-anchored generic manufacturing and multi-country distribution model.

Emerging players

• Lupin: Indian generics and specialty manufacturer with growing distribution in emerging markets. Comparable as an emerging-market manufacturer pushing into CEE/CIS and other geographies, though primarily India-anchored.

Broad incumbents

• Aspen Pharmacare: South African specialty pharma group with manufacturing and distribution across emerging markets globally. Comparable as a larger emerging-market-led pharma platform, but at materially greater scale and geographic breadth.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/alpenpharma
• LinkedInlinkedin.com/company/alpen-pharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alpen Pharma